Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Bellemare

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|December 10, 2009
Modulation of the human glucuronosyltransferase UGT1A pathway by splice isoform polypeptides is mediated through protein-protein interactionsJudith Bellemare, Mélanie Rouleau, Mario Harvey, et al.
Molecular Pharmacology|October 22, 2013
Dual roles for splice variants of the glucuronidation pathway as regulators of cellular metabolismMélanie Rouleau, Joannie Roberge, Judith Bellemare, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 9, 2010
Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitroJudith Bellemare, Mélanie Rouleau, Hugo Girard, et al.
The Biochemical Journal|November 15, 2012
Protein-protein interactions between the bilirubin-conjugating UDP-glucuronosyltransferase UGT1A1 and its shorter isoform 2 regulatory partner derived from alternative splicingMélanie Rouleau, Pierre Collin, Judith Bellemare, et al.
Drug Metabolism Reviews|October 28, 2009
UGT genomic diversity: beyond gene duplicationChantal Guillemette, Eric Lévesque, Mario Harvey, et al.
Pharmacogenetics and Genomics|November 16, 2007
Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activityHugo Girard, Eric Lévesque, Judith Bellemare, et al.
The Journal of Pathology|December 21, 2010
Immunohistochemical expression of conjugating UGT1A-derived isoforms in normal and tumoral drug-metabolizing tissues in humansJudith Bellemare, Mélanie Rouleau, Mario Harvey, et al.
Pharmacogenetics and Genomics|February 9, 2010
Extensive splicing of transcripts encoding the bile acid-conjugating enzyme UGT2B4 modulates glucuronidationEric Lévesque, Vincent Ménard, Isabelle Laverdière, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|November 5, 2020
The Clinical Utility of Determining the Allelic Background of Mutations Causing Alpha-1 Antitrypsin Deficiency: The Case with the Null Variant Q0(Mattawa)/Q0(Ourém)Judith Bellemare, Nathalie Gaudreault, Kim Valette, et al.
The Journal of Pathology|March 18, 2005
Epidermis promotes dermal fibrosis: role in the pathogenesis of hypertrophic scarsJudith Bellemare, Charles J Roberge, Danielle Bergeron, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|December 10, 2009
Modulation of the human glucuronosyltransferase UGT1A pathway by splice isoform polypeptides is mediated through protein-protein interactionsJudith Bellemare, Mélanie Rouleau, Mario Harvey, et al.
Molecular Pharmacology|October 22, 2013
Dual roles for splice variants of the glucuronidation pathway as regulators of cellular metabolismMélanie Rouleau, Joannie Roberge, Judith Bellemare, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 9, 2010
Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitroJudith Bellemare, Mélanie Rouleau, Hugo Girard, et al.
The Biochemical Journal|November 15, 2012
Protein-protein interactions between the bilirubin-conjugating UDP-glucuronosyltransferase UGT1A1 and its shorter isoform 2 regulatory partner derived from alternative splicingMélanie Rouleau, Pierre Collin, Judith Bellemare, et al.
Drug Metabolism Reviews|October 28, 2009
UGT genomic diversity: beyond gene duplicationChantal Guillemette, Eric Lévesque, Mario Harvey, et al.
Pharmacogenetics and Genomics|November 16, 2007
Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activityHugo Girard, Eric Lévesque, Judith Bellemare, et al.
The Journal of Pathology|December 21, 2010
Immunohistochemical expression of conjugating UGT1A-derived isoforms in normal and tumoral drug-metabolizing tissues in humansJudith Bellemare, Mélanie Rouleau, Mario Harvey, et al.
Pharmacogenetics and Genomics|February 9, 2010
Extensive splicing of transcripts encoding the bile acid-conjugating enzyme UGT2B4 modulates glucuronidationEric Lévesque, Vincent Ménard, Isabelle Laverdière, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|November 5, 2020
The Clinical Utility of Determining the Allelic Background of Mutations Causing Alpha-1 Antitrypsin Deficiency: The Case with the Null Variant Q0(Mattawa)/Q0(Ourém)Judith Bellemare, Nathalie Gaudreault, Kim Valette, et al.
The Journal of Pathology|March 18, 2005
Epidermis promotes dermal fibrosis: role in the pathogenesis of hypertrophic scarsJudith Bellemare, Charles J Roberge, Danielle Bergeron, et al.
Pageof 2